For the year ending 2025-12-31, IMA has $152,976K in assets. $19,837K in debts. $94,532K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 94,532 | |||
| Marketable securities | 40,817 | |||
| Prepaid expenses and other current assets | 4,939 | |||
| Total current assets | 140,288 | |||
| Operating lease right-of-use assets, net | 790 | |||
| Promissory note receivable from related party (note 10) | 7,020 | |||
| Other non-current assets | 4,878 | |||
| Deferred offering costs | 0 | |||
| Total assets | 152,976 | |||
| Total redeemable convertible preferred shares | 0 | |||
| Accounts payable | 1,439 | |||
| Deferred revenue, current | 0 | |||
| Term loan | 0 | |||
| Accrued expenses and other current liabilities | 7,533 | |||
| Lease liabilities, current | 2,262 | |||
| Total current liabilities | 11,234 | |||
| Cvr liability due to related party (note 10) | 7,020 | |||
| Other non-current liabilities | 870 | |||
| Lease liabilities, non-current | 713 | |||
| Total liabilities | 19,837 | |||
| Preferred stock value-Series AConvertible Preferred Stock | 0 | |||
| Preferred stock value | 0 | |||
| Common stock value-Voting Common Stock | 11 | |||
| Common stock value-Non-Voting Common Stock | 0 | |||
| Additional paid-in capital | 363,094 | |||
| Accumulated deficit | -230,053 | |||
| Accumulated other comprehensive income (loss) | 87 | |||
| Total stockholders' equity (deficit) | 133,139 | |||
| Total liabilities, redeemable convertible preferred shares and stockholders' equity (deficit) | 152,976 | |||
ImageneBio, Inc. (IMA)
ImageneBio, Inc. (IMA)